RNA evidence supports clinical stage antibody drug targets in oncology
Background: The selection of efficacious and safe antibody-based oncology targets depends on tumor specificity and normal-tissue expression, and remains ch
Background: The selection of efficacious and safe antibody-based oncology targets depends on tumor specificity and normal-tissue expression, and remains ch